Company profile: Stilla Technologies
1.1 - Company Overview
Company description
- Provider of digital PCR solutions to accelerate next-generation genetic testing, including the Nio System, an all-in-one 7-color, continuous-loading instrument for high-throughput analysis; the naica System, a multiplex dPCR platform with up to six fluorescent channels; ready-to-use digital PCR kits and assays; chips and reagents; and analysis software for image analysis and data export.
Products and services
- Naica® System: A multiplex, microfluidic-driven digital PCR platform that produces precise, sensitive quantification of nucleic acids using up to six fluorescent channels for next-generation genetic tests
- Nio™ System: A versatile, high-throughput digital PCR instrument featuring 7-color detection and continuous loading, engineered as an all-in-one platform for accelerated, large-scale genetic analysis
- Digital PCR Chips and Reagents: Consumable digital PCR chips and specially-formulated reagents for use with the Nio™ and naica® systems, supplying instrument-matched consumables to run reproducible digital PCR experiments.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Stilla Technologies
SAW Instruments
HQ: Germany
Website
- Description: Provider of innovative analytical systems for the life sciences market, enabling label-free analysis of molecular biomolecular interactions and combining stability, ease of use, and high sensitivity; develops, manufactures, and sells equipment for life sciences applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SAW Instruments company profile →
IntelliCyt
HQ: United States
Website
- Description: Provider of high-throughput cell and bead-based screening solutions for use throughout the life sciences, leveraging proprietary technologies to deliver instrumentation, reagent kits, and software that increase the speed and reduce the cost of detecting and measuring cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IntelliCyt company profile →
PhoreMost
HQ: United Kingdom
Website
- Description: Provider of phenotypic screening and targeted protein degradation solutions, including the SITESEEKER® platform using PROTEINi® libraries to identify novel drug targets and druggable sites in live cells, and GlueSEEKER™ to discover molecular glue degraders. Offers an oncology-focused pipeline of first-in-class targets and E3 ligase-based degraders, and partnering services applying SITESEEKER® across therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PhoreMost company profile →
AMW
HQ: Germany
Website
- Description: Provider of drug delivery systems, including active ingredient/biodegradable implants and transdermal passive and microchip-controlled patches for oncology, pain therapy, and neurology. Offers biodegradable Goserelin and Leuprorelin implants for hormone-dependent tumors, plus CDMO manufacturing, inhouse innovation, joint development, and regulatory affairs services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AMW company profile →
Arzeda
HQ: United States
Website
- Description: Provider of AI-driven protein and enzyme design and manufacturing for pharmaceuticals, industrial chemicals, and food applications. Offers Intelligent Protein Design Technology to create novel proteins; ProSweet enzymes for efficient production of Reb D and Reb M from stevia; and collaborates with Unilever (cleaning), W. L. Gore (materials), Takeda (therapeutic biologics), and AAK (plant-based oils).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arzeda company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Stilla Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Stilla Technologies
2.2 - Growth funds investing in similar companies to Stilla Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Stilla Technologies
4.2 - Public trading comparable groups for Stilla Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →